DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Gutzmer R, Koop A, Meier F. et al.
Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity.
Eur J Cancer 2017;
75: 24-32
DOI: 10.1016/j.ejca.2016.12.038.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.